Lymph Nodal Plasmacytoma Detected on Myocardial Perfusion Imaging. Revisiting the Past. [PDF]
Mandal S +6 more
europepmc +1 more source
Appropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in Iran [PDF]
Gholamrezanezhad, A. +2 more
core
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley +1 more source
Flipping the Script: Pharmacologic Myocardial Perfusion Imaging and Percutaneous Coronary Intervention in a Patient With Dextrocardia and Situs Inversus Totalis. [PDF]
Lacourt Sosa GL +3 more
europepmc +1 more source
Abstract Background and Purpose Between‐cell differences in ventricular cardiomyocyte action potential duration (APD) and responses to ion channel block may contribute to pro‐arrhythmic dispersion of myocardial repolarisation. This study quantifies between‐cell physiological and pharmacological variability in the rabbit left ventricle (LV) and uses ...
Rebecca J. Gilchrist +5 more
wiley +1 more source
Multicenter Evaluation of Myocardial Flow Reserve as a Prognostic Marker for Mortality in <sup>13</sup>N-Ammonia PET Myocardial Perfusion Imaging. [PDF]
Ramirez G +14 more
europepmc +1 more source
TSP4 is upregulated in human and experimental AAA. TSP4 knockdown accelerated AAA formation and exacerbated both vascular inflammation and remodelling, emphasizing that TSP4 upregulation may represent a protective response against AAA. Our findings suggest that preserving TSP4 could be a useful strategy in the clinical management of AAA.
Laia Blanco‐Casoliva +10 more
wiley +1 more source
Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging. [PDF]
Chen TY +5 more
europepmc +1 more source
Cardiotoxicity of BRAF/MEK inhibitors
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe +4 more
wiley +1 more source
Impact of myocardial perfusion abnormalities on clinical outcomes in patients treated with percutaneous coronary intervention for chronic total occlusions. [PDF]
Henningsen JB +13 more
europepmc +1 more source

